LONDON, UK – January 7, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Alethio Therapeutics – formerly known as Alethiomics – and is pleased to announce the placement of Dr. Rohit Batta as Chief Executive Officer.
by Philippa Clark, Director of Business Development, One Nucleus
Ikarovec to advance pipeline with exclusive worldwide option to VectorBuilder’s Intravitreal Capsid Technology
Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening disease
We’re kicking off the new year with a full calendar of courses covering a broad mix of skills. Whether you’re looking to sharpen existing expertise or explore something new, there’s something for everyone to discover and learn throughout the year.
27 January 2026 | The Safe Use and Management of Laboratory Gases Register Here...
Calling all academics, clinicians, entrepreneurs, start-ups, and industry partners who want to turn early-stage medical technologies into safe, sustainable, clinically ready devices.
eg technology are offering a 12-month paid internship for motivated and creative students (completing a “year in industry”) or recent graduates seeking professional experience.
At eg technology, you’ll:
· Work on real, challenging projects across multiple disciplines.
· Gain hands-on experience in your chosen discipline, mechanical engineering, industrial design and software engineering.
· Receive comprehensive mentoring, guidance and feedback to accelerate your skills and knowledge.
NEW BioBiz Buzz EPISODE ALERT: “From the Horse’s Mouth — Inside Pharma’s Most Volatile Year”
What a year it’s been. Pharma’s first $1 trillion company. A $400 billion collapse. Mass layoffs, geopolitical upheaval, AI valuations soaring, and a regulatory reset that changes everything for rare disease developers.
For over a decade, LSX Europe has brought together the leaders shaping the future of life sciences - and in 2026, we take the Congress to Lisbon for the very first time. It unites the founders and CEOs of early to late stage biotechs, medtechs and healthtechs with global investors, pharma and the partners driving innovation forward.
See who’s already joining us in 2026: https://informaconnect.com/lsx-world-congress/2026-attendees/
Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease.
The future is coming. A future enabled and enriched by the incredible power of machine learning. A future in which diseases are curtailed or cured starting with better and faster drug discovery.
At Mestag we truly believe in our values and live by them every day. We’re ambitious about our science and its potential to deliver meaningful therapeutics to the patients that need them most. We believe in a culture of diversity, equality and investing in people to ensure our talented and passionate team members can fulfil their full potential.
We are now transitioning our lead programme into clinic - There has never been a better time to join #TeamMestag